Experience with using fosfestrol for treating metastatic castrate-resistant prostate cancer in resource-limited setting

Background: Fosfestrol is a low-cost estrogen analog that is useful in the management of metastatic prostate cancer in resource-challenged settings. It acts by altering the pituitary axis, adrenal secretion, and 5-alpha reductase activity. Patients and Methods: The outcomes of metastatic castration-...

詳細記述

書誌詳細

出版年:	Indian Journal of Medical and Paediatric Oncology
主要な著者:	Jayachandran Perumal Kalaiyarasi, Venkatraman Radhakrishnan, Trivadi S Ganesan, Anand Raja, Prasanth Ganesan, Manikandan Dhanushkodi, Tenali Gnana Sagar
フォーマット:	論文
言語:	英語
出版事項:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2019-01-01
主題:	Castration-resistant prostate cancer diethylstilbestrol diphosphate fosfestrol prostate-specific antigen survival
オンライン･アクセス:	http://www.ijmpo.org/article.asp?issn=0971-5851;year=2019;volume=40;issue=1;spage=79;epage=84;aulast=